BRAF and colorectal cancer: The majority of patients (65.6%, n = 82/125) had a node-positive index colorectal cancer, while the pathology showed mucinous type adenocarcinoma in 28% (n = 35/125), and 8% (n = 10/125) were BRAF mutated.